Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Washington University School of Medicine